Pneumonia
1,356 results
1 - 100
Pneumonia 
Corticosteroids for pneumonia- Eosinophilic pneumonia
- Pneumonia in children
Oral antiseptics reduce ventilator-associated pneumonia- Recovery from pneumonia - Audio
- Lobar pneumonia (PA view) - Image
- Lobar pneumonia (lateral view) - Image
- Chest physiotherapy for pneumonia in children
- Antibiotics for community‐acquired pneumonia in children
- Chest PT not effective for kids with pneumonia
- GERD tx in children assoc with pneumonia risk
- Vitamin C supplementation for prevention and treatment of pneumonia
- Pneumonia vaccine effective in nursing homes
- Acute stage of pneumonia - Audio
- Guidelines for pediatric pneumonia from BTS
- Steroids = placebo in community acquired pneumonia
- Fluoroquinolones effective for community-acquired pneumonia
- Vitamin A for non‐measles pneumonia in children
- Antibiotics for hospital‐acquired pneumonia in neonates and children
- Antibiotics for ventilator‐associated pneumonia
- Pneumonia: 3 days of antibiotics for uncomplicated course
- Diagnosis of pneumonia by history and physical examination
- In-hospital PPI use associated with hospital-acquired pneumonia
- Vitamin C for preventing and treating pneumonia: Cochrane systematic review
- Quinolones for treatment of hospital-acquired pneumonia
- Inhaled steroids for COPD associated with increased risk of pneumonia
- CURB65 rule as accurate as pneumonia severity index
- Inhaled budesonide for COPD not associated with pneumonia
- Chest physiotherapy for pneumonia in adults
- Pneumonia can be treated with 3 to 5 days of abx
- Antibiotics for community acquired pneumonia in adult outpatients
- Urinary antigen test useful for diagnosis of pneumococcal pneumonia
- Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease
- Lung ultrasound accurate for diagnosis of pneumonia in adults
- Low rate of bacteremia in children hospitalized with pneumonia
- Community-acquired pneumonia: Most oral treatments are similarly effective
- Steroids beneficial as adjunctive treatment for community-acquired pneumonia
- Inhaled corticosteroids increase pneumonia risk in stable COPD
- Clinical signs and symptoms of pneumonia unreliable in children
- Oxygen therapy for pneumonia in adults: Cochrane systematic review
- Dexamethasone reduces LOS in patients with community-acquired pneumonia
- Comparison of different antibiotics for community acquired pneumonia in children
- Probiotics for preventing ventilator‐associated pneumonia
- Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
- Antibiotics for treating community‐acquired pneumonia in people with sickle cell disease
- Oral care measures for preventing nursing home‐acquired pneumonia
- Oral antibiotics versus parenteral antibiotics for severe pneumonia in children
- Fluticasone + salmeterol may reduce mortality but also increase pneumonia in COPD
- Serum procalcitonin not very accurate in diagnosing children with pneumonia
- Surfactant for bacterial pneumonia in late preterm and term infants: Cochrane systematic review
- Corticosteroids improve outcomes in patients with severe community-acquired pneumonia
- Prophylaxis for Pneumocystis pneumonia in non-HIV immunocompromised patients
- Most common identified causes of community-acquired pneumonia are viruses
- Linezolid no better than vancomycin for treatment of nosocomial pneumonia
- Vancomycin plus rifampicin effective in treatment of nosocomial MRSA pneumonia
- Risk of serious pneumonia in COPD patients using inhaled corticosteroids
- More expensive omadacycline no worse than moxifloxacin for community-acquired pneumonia
- Evidence does not show benefit of treating mycoplasma pneumonia in children
- Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection
- Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
- Net benefit with azithromycin use in elderly hospitalized patients with pneumonia
- Implementation of 3-step pathway reduces LOS for hospitalized pneumonia patients
- Early mobilization in hospitalized patients with community acquired pneumonia
- Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia
- Overuse alert: Prophylactic abx don't prevent poststroke pneumonia in patients with dysphagia
- Very expensive lefamulin is no worse than moxifloxacin for community-acquired pneumonia
- Lung ultrasound reduces need for CXR in children with suspected pneumonia
- Prophylactic treatments against pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients
- Three-day course of inhaled amikacin is effective in preventing ventilator-associated pneumonia
- Intravenous hydrocortisone reduces all-cause mortality in severe community-acquired pneumonia (CAPE COD)
- Prophylaxis for Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients
- Useful signs and symptoms for diagnosing pneumonia in children younger than 5 years
- Reliability of some clinical exam findings is dubious in children with suspected pneumonia
- Duration of antibiotic therapy for ventilator-associated pneumonia in critically ill adults
- Excess treatment with antibiotics for pneumonia is common and may lead to harm
- Three days of amoxicillin is effective for pneumonia with tachypnea in young children
- Procalcitonin rules out pneumonia in patients with dyspnea in the emergency department
- Inappropriate diagnosis of community-acquired pneumonia in hospitalized patients is common among older adults
- Scores based on bedside clinical findings are helpful in identifying pneumonia in febrile children
- Short‐course versus prolonged‐course antibiotic therapy for hospital‐acquired pneumonia in critically ill adults
- Early tracheotomy ineffective at preventing ventilator-associated pneumonia in mechanically ventilated ICU patients
- Empiric antibiotic coverage of atypical pathogens for community‐acquired pneumonia in hospitalized adults
- Oral hygiene care for critically ill patients to prevent ventilator‐associated pneumonia
- Pneumococcal conjugate vaccines for preventing invasive pneumococcal disease and pneumonia in children aged up to five years
- Systemic corticosteroids reduce need for ICU or mechanical ventilation in patients with community-acquired pneumonia
- Shorter courses of antibiotics for community-acquired pneumonia at least as good as longer courses
- Fewer exacerbations but somewhat more pneumonia with triple inhaler therapy for COPD (IMPACT)
- Convalescent plasma does not improve outcomes in patients hospitalized with severe COVID-19 pneumonia (PlasmAr)
- C-reactive protein is the most useful biomarker for diagnosis of outpatient community-acquired pneumonia
- Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection
- Fewer new clots using high-dose prophylactic anticoagulation for patients with hypoxemic COVID-19 pneumonia (ANTICOVID)
- Decreased risk of mechanical ventilation with tocilizumab for treatment of moderate to severe COVID-19 pneumonia
- Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
- Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO‐defined non‐severe pneumonia and wheeze
- Combination of baricitinib and remdesivir reduces recovery time in patients hospitalized with COVID-19 pneumonia
- No improvement in clinical status at 28 days with tocilizumab in patients with severe COVID-19 pneumonia
- Daily (or more frequent) toothbrushing is associated with lower rates of hospital-acquired pneumonia in ICU patients
- Tofacitinib reduces composite outcome of death or respiratory failure in patients with COVID-19 pneumonia (NNT = 9)
- Lower risk of early ventilator-associated pneumonia with antibiotics in patients with out-of-hospital cardiac arrest